MobiusHD

DEVICE5 trials

Sponsors

Vascular Dynamics, Inc.

Conditions

Heart Failure With Reduced Ejection FractionHypertensionResistant HypertensionUncontrolled Hypertension

Unknown Phase

Controlling and Lowering Blood Pressure With The MOBIUS HD™ (CALM-FIM_EUR)

CompletedNCT01911897

Vascular Dynamics, Inc.Hypertension

Start: 2013-06-30End: 2020-02-28Updated: 2023-11-22

Controlling And Lowering Blood Pressure With the MobiusHDTM Device

TerminatedNCT02804087

Vascular Dynamics, Inc.Hypertension

Start: 2017-08-24End: 2021-07-21Updated: 2023-10-10

CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

Active, not recruitingNCT03179800

Vascular Dynamics, Inc.Hypertension, Resistant Hypertension

Start: 2017-10-19End: 2025-05-31Target: 300Updated: 2024-07-18

Effect of the MobiusHD® in Patients With Heart Failure

RecruitingNCT04590001

Vascular Dynamics, Inc.Heart Failure With Reduced Ejection Fraction

Start: 2020-10-02End: 2026-06-30Target: 50Updated: 2024-02-14

Effect of the MobiusHD® in Renal Hemodialysis Subjects With Uncontrolled Hypertension

WithdrawnNCT05352425

Vascular Dynamics, Inc.Uncontrolled Hypertension

Start: 2022-05-31End: 2022-10-10Updated: 2023-05-10

Related Papers

Treatment of Resistant Hypertension With Endovascular Baroreflex Amplification: 3-Year Results From the CALM-FIM Study.

2022-02-0125 citations

Endovascular baroreflex amplification for resistant hypertension: a safety and proof-of-principle clinical study.

2017-09-0169 citations